BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24284322)

  • 1. Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein.
    Malik-Soni N; Frappier L
    J Virol; 2014 Feb; 88(4):2323-6. PubMed ID: 24284322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4.
    Lin A; Wang S; Nguyen T; Shire K; Frappier L
    J Virol; 2008 Dec; 82(24):12009-19. PubMed ID: 18922874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections.
    Malik-Soni N; Frappier L
    J Virol; 2012 Jun; 86(12):6999-7002. PubMed ID: 22496234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBNA1.
    Frappier L
    Curr Top Microbiol Immunol; 2015; 391():3-34. PubMed ID: 26428370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer.
    Mansouri S; Pan Q; Blencowe BJ; Claycomb JM; Frappier L
    J Virol; 2014 Oct; 88(19):11166-77. PubMed ID: 25031339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the EBNA1 Epstein-Barr virus protein by serine phosphorylation and arginine methylation.
    Shire K; Kapoor P; Jiang K; Hing MN; Sivachandran N; Nguyen T; Frappier L
    J Virol; 2006 Jun; 80(11):5261-72. PubMed ID: 16699006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal transactivation by Epstein-Barr nuclear antigen 1 requires the UR1 and ATH1 domains.
    Singh G; Aras S; Zea AH; Koochekpour S; Aiyar A
    J Virol; 2009 May; 83(9):4227-35. PubMed ID: 19244333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spacing between adjacent binding sites in the family of repeats affects the functions of Epstein-Barr nuclear antigen 1 in transcription activation and stable plasmid maintenance.
    Hebner C; Lasanen J; Battle S; Aiyar A
    Virology; 2003 Jul; 311(2):263-74. PubMed ID: 12842617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus
    Mei Y; Messick TE; Dheekollu J; Kim HJ; Molugu S; Muñoz LJC; Moiskeenkova-Bell V; Murakami K; Lieberman PM
    J Virol; 2022 Sep; 96(17):e0094922. PubMed ID: 36037477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleosome assembly proteins bind to Epstein-Barr virus nuclear antigen 1 and affect its functions in DNA replication and transcriptional activation.
    Wang S; Frappier L
    J Virol; 2009 Nov; 83(22):11704-14. PubMed ID: 19726498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
    Sivachandran N; Sarkari F; Frappier L
    PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.
    Valentine R; Dawson CW; Hu C; Shah KM; Owen TJ; Date KL; Maia SP; Shao J; Arrand JR; Young LS; O'Neil JD
    Mol Cancer; 2010 Jan; 9():1. PubMed ID: 20051109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
    Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
    J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation sites of Epstein-Barr virus EBNA1 regulate its function.
    Duellman SJ; Thompson KL; Coon JJ; Burgess RR
    J Gen Virol; 2009 Sep; 90(Pt 9):2251-9. PubMed ID: 19439552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a cancer-associated Epstein-Barr virus EBNA1 variant reveals a novel interaction with PLOD1 and PLOD3.
    Shire K; Marcon E; Greenblatt J; Frappier L
    Virology; 2021 Oct; 562():103-109. PubMed ID: 34304093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-Barr virus C promoter, EBNA1 and oriP, participating in long-distance promoter-enhancer interactions.
    Boreström C; Forsman A; Rüetschi U; Rymo L
    J Gen Virol; 2012 May; 93(Pt 5):1065-1075. PubMed ID: 22302879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple EBNA1-binding sites within oriPI are required for EBNA1-dependent transactivation of the Epstein-Barr virus C promoter.
    Zetterberg H; Boreström C; Nilsson T; Rymo L
    Int J Oncol; 2004 Sep; 25(3):693-6. PubMed ID: 15289871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus.
    Westhoff Smith D; Sugden B
    Viruses; 2013 Jan; 5(1):226-40. PubMed ID: 23325328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
    Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
    Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.